Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice

Cellular and Molecular Immunology

Volumn 10, Issue 4, 2013, Pages 338-348

  Ma, Tian ^a   Gao, Qi ^a   Zhu, Faliang ^a   Guo, Chun ^a   Wang, Qun ^a   Gao, Fei ^b   Zhang, Lining ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

atherosclerosis; mice; plaque rupture; Th1; Th17

Indexed keywords

APOLIPOPROTEIN E; INTERLEUKIN 17; LIPOPOLYSACCHARIDE; PHENYLEPHRINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; ATHEROSCLEROTIC PLAQUE RUPTURE; CAROTID ARTERY LIGATION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KNOCKOUT MOUSE; LIPID DIET; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SMOOTH MUSCLE FIBER; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIGENS, CD4; APOLIPOPROTEINS E; CAROTID ARTERIES; CELLS, CULTURED; COLD TEMPERATURE; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; PHENYLEPHRINE; PLAQUE, ATHEROSCLEROTIC; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

MURINAE; MUS;

EID: 84879902475     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2013.4     Document Type: Article

References (49)

1. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc 2009; 84: 917-938.
2. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part II. Mayo Clin Proc 2009; 84: 1021-1036.
3. Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM. Advanced atheroscleroticlesions in the innominate artery of the Apo E knockout mouse. Arterioscler Thromb Vasc Biol 2000; 20: 2587-2592.
4. Zaman AG, Helft G, Worthley SG, Badimon JJ. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 2000; 149: 251-266. (Pubitemid 30145535)
5. Rekhter MD. Howtoevaluate plaquevulnerability inanimal modelsof atherosclerosis? Cardiovasc Res 2002; 54: 36-41.
6. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874. (Pubitemid 36019640)
7. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.
8. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989; 135: 169-175. (Pubitemid 19229001)
9. Hosono M, de Boer OJ, van der Wal AC, van der Loos CM, Teeling P, Piek JJ et al. Increasedexpressionof Tcellactivation markers(CD25, CD26, CD40Land CD69) in atherectomy specimensof patientswith unstable angina and acute myocardial infarction. Atherosclerosis 2003; 168: 73-80.
10. Wigren M, Nisson J, Kolbus D. Lymphocytes in atherosclerosis. Clin Chim Acta 2012; 413: 1562-1568.
11. Vinson A, Curran JE, Johnson MP, Dyer TD, Moses EK, Blangero J et al. Genetical genomics of Th1 and Th2 immune response in a baboon model of atherosclerosis risk factors. Atherosclerosis 2011; 217: 387-394.
12. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007; 6: 169-175. (Pubitemid 46187336)
13. -/- mice. Cytokine 2010; 49: 185-193.
14. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO et al. Transforming growth factor-beta induces development of the T (H) 17 lineage. Nature 2006; 441: 231-234.
15. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al. Adistinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141. (Pubitemid 41541791)
16. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producingTcells. Immunity 2006; 24: 179-189. (Pubitemid 43214587)
17. Gao Q, Jiang Y, Ma T, Zhu F, Gao F, Zhang P et al. Acritical functionof Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol 2010; 185: 5820-5827.
18. Afzali GL, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32-46. (Pubitemid 46365005)
19. Yao R, Ma Y, Du Y, Liao M, Li H, Liang W et al. Thealtered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome. Cell Mol Immunol 2011; 8: 486-495.
20. Li Q, Wang Y, Chen K, Zhou Q, Wei W, Wang Y et al. Theroleofoxidized low-density lipoprotein in breaking peripheral Th17/Treg balance in patients with acute coronary syndrome. Biochem Biophys Res Commun 2010; 394: 836-842.
21. Alexander MR, Moehle CW, Johnson JL, Yang Z, Lee JK, Jackson CL et al. Genetic inactivation of IL-1 signalingenhancesatherosclerotic plaque instabilityandreducesoutwardvessel remodelinginadvanced atherosclerosis in mice. J Clin Invest 2012; 122: 70-79.
22. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127: 89-97.
23. Calara F, Silvestre M, Casanada F, Yuan N, Napoli C, Palinski W. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficientand LDLreceptor-deficient mice. J Pathol 2001; 195: 257-263. (Pubitemid 32899037)
24. Hu W, Polinsky P, Sadoun E, Rosenfeld ME, Schwartz SM. Atherosclerotic lesions in the common coronary arteries of Apo E knockout mice. Cardiovasc Pathol 2005; 14: 120-125. (Pubitemid 40725587)
25. Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 2001; 154: 399-406. (Pubitemid 32146612)
26. Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM. Advanced atherosclerotic lesions in the innominate arteryof the Apo E knockout mouse. Arterioscler Thromb Vasc Biol 2000; 20: 2587-2592.
27. Williams H, Johnson JL, Carson KG, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2002; 22: 788-792. (Pubitemid 34517790)
28. Johnson J, Carson K, Williams H, Karanam S, Newby A, Angelini G et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 2005; 111: 1422-1430. (Pubitemid 40396809)
29. von der Thüsen JH, van Berkel TJ, Biessen EA. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 2001; 103: 1164-1170. (Pubitemid 32200193)
30. -/- miceafteradenovirus-mediatedtransferofp53. Circulation 2002; 105: 2064-2070. (Pubitemid 34465269)
31. Ni M, Wang Y, Zhang M, Zhang PF, Ding SF, Liu CX et al. Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice. Am J Physiol Heart Circ Physiol 2009; 296: H1598-H1606.
32. Ni M, Chen WQ, Zhang Y. Animal modelsand potential mechanismsof plaque destabilization and disruption. Heart 2009; 95: 1393-1398.
33. Shah PK. Mechanisms of plaque vulnerability and rupture. JAm Coll Cardiol 2003;41: 15S-22S. (Pubitemid 36223342)
34. Anogeianaki A, Angelucci D, Cianchetti E, D'Alessandro M, Maccauro G, Saqqini A et al. Atherosclerosis: a classic inflammatorydisease. Int JImmunopathol Pharmacol 2011; 24: 817-825.
35. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006; 37: 1923-1932. (Pubitemid 44297753)
36. -/- mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 1996; 16: 1013-1018. (Pubitemid 26266901)
37. + Tcells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000; 102: 2919-2922.
38. Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR et al. Increased Th1 activityin patientswithcoronaryarterydisease. Cytokine 2004; 26: 131-137.
39. -/- mice. J Interferon Cytokine Res 2002; 22: 661-670. (Pubitemid 35034524)
40. Robertson AK, Hansson GK. T cells in atherogenesis: for better or for worse? Arterioscler Thromb Vasc Biol 2006; 26: 2421-2432. (Pubitemid 44607461)
41. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345-352. (Pubitemid 41716771)
42. + Tregs and T helper 1 cells in acute coronary syndromes. Clin Immunol 2007; 124: 90-97. (Pubitemid 46936250)
43. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006; 12: 178-180. (Pubitemid 43214743)
44. Foks AC, Frodermann V, ter Borg M, Habets KL, Bot I, Zhao Y et al. Differentialeffectsof regulatoryTcellsontheinitiationandregression of atherosclerosis. Atherosclerosis 2011; 218: 53-60.
45. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamaté C, Merval R et al. Inhibition of transforming growth factor-b signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001; 89: 930-934. (Pubitemid 34627899)
46. Kolodgie FD, Narula J, Haider N, Virmani R. Apoptosis in atherosclerosis. Does it contribute to plaque instability? Cardiol Clin 2001; 19: 127-139. (Pubitemid 32433920)
47. Kockx M. Apoptosis in the atherosclerotic plaque. Aeterioscler Thromb Vasc Biol 1998; 18: 1519-1522.
48. Sato K, Niessner A, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque. J Exp Med 2006; 203: 239-250. (Pubitemid 43139661)
49. Zhu F, Wang Q, Guo C, Wang X, Cao X, Zhang L et al. IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. Clin Immunol 2011; 141: 152-160.